QPS Celebrates 30th Anniversary

News

QPS Celebrates 30th Anniversary

2025-06-04 23:58 Last Updated At：06-05 00:11

NEWARK, Del.--(BUSINESS WIRE)--Jun 4, 2025--

QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalytics and clinical trials, is celebrating its 30-year anniversary in 2025. Founded by Dr. Benjamin Chien in 1995 to provide high-quality bioanalytical liquid chromatography with tandem mass spectrometry (LC-MS/MS) contract services, QPS is now recognized as a global leader in contract research. Over the past 30 years, the company has grown from a single office in Delaware, USA to a widely respected, global, full-service CRO with 8 locations spread across the US, EU, Asia, India and Australia, a clinical trial network of over 700 sites and an increased focus on leveraging the power of AI to accelerate clinical trials.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250604778675/en/

Over the years, QPS has grown from a small molecule bioanalysis shop of three people to a global CRO with more than 1,200 employees. “30 years is a major milestone for QPS and I couldn’t be more proud of the hard-working and innovative people who choose to work at QPS. They are the backbone of the company, and I am very grateful for their valuable contributions,” said founder and CEO of QPS, Dr. Benjamin Chien.

“Through QPS, the pharmaceutical and biotechnology industries have access to dedicated, focused scientific expertise across the drug development spectrum. In facilities around the world, QPS has assembled best-in-class instruments, platforms, people and processes required to conduct the studies necessary to support client drug discovery and development programs focused on obesity, type 2 diabetes, oncology, CNS diseases, cell and gene therapy, and more,” said Dr. Chien.

Since its humble beginnings, QPS has expanded its service options, to include pharmacology, DMPK, toxicology, bioanalysis, translational medicine, leukopaks, PBMCs, cell therapy products, clinical trials, central lab services, and a full range of clinical research services.

QPS is known for high-quality data, technical expertise, delivery of promised study timelines, collaborative solutions, and customer-focused strategies. Going forward, QPS plans to continue delivering custom-built research services that accelerate pharmaceutical breakthroughs across the globe.

ABOUT QPS HOLDINGS, LLC

QPS is a global, full-service, GLP/GCP-compliant contract research organization (CRO) delivering the highest grade of discovery, bioanalysis, preclinical and clinical drug development services. Since 1995, QPS has grown from a small bioanalysis shop into a full-service CRO with 1,200+ employees in the US, Europe, Asia and Australia. Today, QPS offers expanded pharmaceutical contract R&D services with special expertise in pharmacology, DMPK, toxicology, bioanalysis, translational medicine, leukopaks, PBMCs and cell therapy products, clinical trials, and clinical research services. An award-winning leader focused on bioanalysis and clinical trials, QPS is known for proven quality standards, technical expertise, a flexible approach to research, client satisfaction, and turnkey laboratories and facilities. Through continual enhancements in capacities and resources, QPS stands tall in its commitment to delivering superior quality, skilled performance and trusted service to its valued customers. For more information, visit www.qps.com or email info@qps.com.

The Golden Globes are tonight. Here's what to look for and how to watch and stream the show

The Golden Globes bill themselves as Hollywood’s booziest bash. This year, is anyone ready to party?

Political tension and industrywide uncertainty are the prevailing moods heading into Sunday night's 83rd Golden Globes. Hollywood is coming off a disappointing box-office year and now anxiously awaits the fate of one of its most storied studios, Warner Bros.

A celebratory mood might be even more elusive given that the wide majority of the performers and filmmakers congregating at the Beverly Hilton in Beverly Hills, California, oppose the policies of President Donald Trump. Likely to be on the minds of many attendees: the recent U.S. involvement in Venezuela and the fatal shooting of 37-year-old mother Renee Good in Minneapolis by Immigration and Customs Enforcement.

But through their ups and downs, the Globes have always tried to put pomp over politics. Host Nikki Glaser has vowed as much.

“You’d be surprised that half the room had no clue why I was saying ‘Venezuela,’” Glaser told The Associated Press earlier in the week, referring to her comedy-club warm-ups. “People aren’t getting the news like we all are.”

Glaser, a comic known for her roast appearances, has promised to go after A-listers in her second time hosting.

“We’re going to hit Leo,” Glaser said. “The icebergs are coming.”

Here’s what to look for at this year’s Globes:

The Golden Globes kick off at 8 p.m. EST on CBS while streaming live for Paramount+ premium subscribers. E!’s red carpet coverage begins at 6 p.m. EST.

The Associated Press will be have a livestream show beginning at 4:30 p.m. Eastern with a mix of stars' arrivals, fashion shots and celebrity interviews. It will be available on YouTube and APNews.

The overwhelming Oscar favorite “One Battle After Another” comes in with a leading nine nominations. It’s competing in the Globes’ musical or comedy category, which means the drama side might be more competitive. There, Ryan Coogler’s “Sinners,” Chloé Zhao’s “Hamnet” and Joachim Trier’s “Sentimental Value” are all in the mix.

But thus far, “One Battle After Another” has cleaned up just about everywhere. Much of Paul Thomas Anderson’s cast is nominated, including DiCaprio, Teyana Taylor, Sean Penn, Chase Infiniti and Benicio Del Toro.

If it and “Sinners” take home the two biggest prizes, it will be a banner night for Warner Bros. even as its future hangs in the balance. The studio has agreed to be acquired by Netflix is a deal worth $82.7 billion. Movie theaters have warned such a result would be “a direct and irreversible negative impact on movie theaters around the world.”

The merger awaits regulatory approval, while Paramount Skydance is still trying to convince Warner shareholders to accept its rival offer.

After an audacious promotional tour for “Marty Supreme,” Timothée Chalamet is poised to win his first Globe in five nominations. In best actor, comedy or musical, he’ll have to beat DiCaprio, a three-time Globe winner, and Ethan Hawke (“Blue Moon”).

In best actress, comedy or musical, Rose Byrne is the favorite for her performance in the not especially funny A24 indie “If I Had Legs I’d Kick You.” One prominent nominee in the category, Cynthia Erivo (“Wicked: For Good”), won’t be attending due to her schedule in the West End production “Dracula.”

Jessie Buckley (“Hamnet”) is the clear front-runner in best actress, drama. In the star-studded best actor, drama, category, the Brazilian actor Wagner Moura (“The Secret Agent”) may win over Michael B. Jordan (“Sinners”) and Joel Edgerton (“Train Dreams”).

In the supporting categories, Teyana Taylor and Stellan Skarsgård come in the favorites.

The Globes, formerly presented by the Hollywood Foreign Press Association, have no overlap or direct correlation with the Academy Awards. After being sold in 2023 to Todd Boehly’s Eldridge Industries and Dick Clark Productions, a part of Penske Media, the Globes are voted on by around 400 people. The Oscars are voted on by more than 10,500 professionals.

But in the fluctuating undulations of awards season, a good speech at the Globes can really boost an Oscar campaign. Last year, that seemed to be the case for Demi Moore, who won for “The Substance” and gave the night's most emotional speech. Mikey Madison (“Anora”), however, scored the upset win at the Oscars.

A few potentially good moments this year went instead in a Golden Eve ceremony earlier this week. There, the Cecil B. DeMille and Carol Burnett honorees, Helen Mirren and Sarah Jessica Parker, accepted their awards.

One to watch, if he wins, will be the Iranian director Jafar Panahi. His revenge drama “It Was Just an Accident” is up for four awards. Panahi has spent most of his career making films clandestinely, without approval of authorities, and was until recently banned from leaving the country. Last month, he was sentenced to a year in prison, which would be only his latest stint behind bars if Panahi returns home to serve it. This week, protests over Iran’s ailing economy have spread throughout the country in a new test to Iran's leaders.

For the first time, the Globes are trotting out a new podcast category. The nominees are: “Armchair Expert,” “Call Her Daddy,” “Good Hang With Amy Poehler,” “The Mel Robbins Podcast,” “SmartLess” and “Up First.”

In TV, HBO Max’s “The White Lotus” — another potential big winner for Warner Bros. — leads with six nominations. Netflix’s “Adolescence” comes in with five nods.

But the most closely watched nominee might be “The Studio.” The first season of Seth Rogen’s Hollywood satire memorably included an episode devoted to drama around a night at the Globes. (Sample line: “I remember when the red carpet of the Golden Globes actually stood for something.”) “The Studio” is up for three awards, giving three chances for life to imitate art.

For more coverage of this year’s Golden Globe Awards, visit: https://apnews.com/hub/golden-globe-awards